Taiwan FDA registration 8e9aa169beeea3fc9cb29b5c3f1d1676
"Abbott" Sainz Tianshan Inoli Mos coronary artery coating stent system
TW: “雅培” 賽恩斯天山艾諾莉茉斯冠狀動脈塗藥支架系統
Taiwan·Risk Class 3·ABBOTT VASCULAR·Registered Oct 26, 2023 – Oct 26, 2028ActiveRegistration details
- Analysis ID
- 8e9aa169beeea3fc9cb29b5c3f1d1676
- Customs Code
- DHA05603638304
Company information
- Manufacturer
- ABBOTT VASCULAR
- Manufacturer Country
- Ireland
- Authorized Representative
- Abbott Medical Taiwan Co.
Product details
- Intended Use
- Details are as detailed as approved Chinese instructions
- Product Type (Level 1)
- E Cardiovascular Medicine Science
- Product Type (Level 2)
- E.0001 Cardiovascular stents
- Import Information
- Safety monitoring;; import
Dates and status
- Registration Date
- Oct 26, 2023
- Expiry Date
- Oct 26, 2028
About this record
Access comprehensive regulatory information for "Abbott" Sainz Tianshan Inoli Mos coronary artery coating stent system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 8e9aa169beeea3fc9cb29b5c3f1d1676 and manufactured by ABBOTT VASCULAR. The authorized representative in Taiwan is Abbott Medical Taiwan Co..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices